$18.30
0.54 (-2.87%)
Last updated: May 31, 2026 03:07
Fundamentals Overview
USANA Health Sciences, Inc. is near the low of its 52-week range with premium valuation, trending downward today.
Valuation premium
Intrinsic value (DCF)
+402% upside vs price
Profitability
Risk (Beta)
0.77 — lower vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +402% upside vs price · Analyst grade: A-
Pressures (Sell):
Sentiment weakening (8 downgrades) · 3M vs S&P 500: -23.1% · 3M vs Consumer Defensive sector: -17.2%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 7, Hold: 4, Neutral: 18, Underperform: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $91.86; current price is $18.30. That’s a +402% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 37.97 |
| DCF value (model) | $91.86 (402% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 0.62 |
| P/S (TTM) | 0.36 |
| P/FCF (TTM) | 114.11 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 2.51 |
| Quick Ratio (TTM) | 1.69 |
| Cash Ratio (TTM) | 1.39 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 0.96% |
| Gross margin (TTM) | 76.72% |
| Operating margin (TTM) | 5.3% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for USNA.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| DA Davidson | maintain | Neutral | Neutral | 2025-02-27 |
| DA Davidson | maintain | Neutral | Neutral | 2025-01-02 |
| DA Davidson | maintain | Neutral | Neutral | 2024-10-23 |
| DA Davidson | maintain | Neutral | Neutral | 2024-07-25 |
| DA Davidson | maintain | Neutral | Neutral | 2024-05-07 |
| DA Davidson | maintain | Neutral | Neutral | 2024-02-22 |
| DA Davidson | maintain | Neutral | Neutral | 2023-10-25 |
| DA Davidson | maintain | Neutral | Neutral | 2023-04-26 |
| DA Davidson | maintain | Neutral | Neutral | 2023-02-13 |
| DA Davidson | maintain | Neutral | Neutral | 2022-10-27 |
| DA Davidson | maintain | Neutral | Neutral | 2022-07-28 |
| DA Davidson | maintain | Neutral | Neutral | 2022-07-12 |
| Jefferies | downgrade | Hold | Underperform | 2022-07-07 |
| DA Davidson | maintain | Neutral | Neutral | 2022-04-27 |
| DA Davidson | maintain | Neutral | Neutral | 2022-04-14 |
| Roth Capital | maintain | Buy | Buy | 2021-02-10 |
| Roth Capital | maintain | Buy | Buy | 2020-12-17 |
| Jefferies | maintain | Hold | Hold | 2019-08-22 |
| Sidoti & Co. | downgrade | Buy | Neutral | 2019-07-03 |
| Tigress Financial | maintain | Buy | Buy | 2019-04-16 |
| Pivotal Research | downgrade | Buy | Hold | 2018-04-23 |
| Sidoti & Co. | downgrade | Buy | Neutral | 2018-01-24 |
| Pivotal Research | upgrade | Hold | Buy | 2017-05-03 |
| Pivotal Research | downgrade | Buy | Hold | 2017-05-01 |
| DA Davidson | downgrade | Buy | Neutral | 2016-02-10 |
| DA Davidson | upgrade | Neutral | Buy | 2015-09-16 |
| DA Davidson | downgrade | Buy | Neutral | 2015-08-06 |
| DA Davidson | maintain | Buy | Buy | 2015-06-26 |
| Pivotal Research | downgrade | Buy | Hold | 2015-04-27 |
| Pivotal Research | maintain | Buy | Buy | 2014-10-20 |